Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study

Editor’s Choice: Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort studyEditorial: Prevention of Gestational Trophoblastic Neoplasia with Actinomycin -D at the time of evacuation: A Matter of Routine Practice or Reserve for Special Circumstances?Hosted by:David Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic OncologyFeaturing:Elza Maria Hartmann Uberti, MD, Coordinator of the Center for Trophoblastic Diseases at Maternidade Mario Totta of Irmandade de Santa Casa de Misericórdia de Porto Alegre (ISCMPA), BrazilNeil S. Horowitz, MD, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology Mass General Brigham, Harvard Medical School, Boston, MA, United StatesCheck out more content on the journal's homepage  at https://www.gynecologiconcology-online.net